Lesson plan

Trepipam

Trepipam ( ; developmental code name SCH-12679) is a dopamine receptor agonist of the benzazepine group that was never marketed. It acts specifically as an agonist of the dopamine D 1 receptor. It is closed related structurally to fenoldopam, a peripherally acting selective D 1 receptor partial agonist which is used as an antihypertensive agent.

Back to article

Article summary

Trepipam ( ; developmental code name SCH-12679) is a dopamine receptor agonist of the benzazepine group that was never marketed. It acts specifically as an agonist of the dopamine D 1 receptor. It is closed related structurally to fenoldopam, a peripherally acting selective D 1 receptor partial agonist which is used as an antihypertensive agent.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.